Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin cardiovascular use labeling should advise physician consultation -- McNeil.

This article was originally published in The Tan Sheet

Executive Summary

ASPIRIN LABEL WITH PHYSICIAN CONSULTATION INSTRUCTIONS FOR CARDIOVASCULAR USERS suggested by McNeil Consumer Products in April 14 comments to FDA. McNeil, the maker of Tylenol brand acetaminophen, says in the letter that "consumer labeling for aspirin should advise patients taking low-dose aspirin under their physician's care for cardiovascular indications to consult with their physician on appropriate analgesic or antipyretic use."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel